Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of a bioelectronic implant designed to improve adherence for obesity and type 2 diabetes (T2D) treatment while reducing development and manufacturing costs.
Psychedelics Companies Reeling After FDA Vote | Psychedelic Invest
Here’s what investors need to know. Shares of prominent psychedelics companies, including Compass Pathways, Atai Life Sciences, and Mind Medicine, experienced a significant decline following